Overview
For researchers conducting clinical trials in Canada, understanding the key rules of Good Clinical Practices (Health Canada) is essential for ensuring participant safety, data integrity, and regulatory compliance. Governed by Part C, Division 5 of the Food and Drug Regulations and aligned with ICH E6(R3), these rules provide the framework for ethical and scientifically sound clinical research. This guide explores the key rules that every researcher must know and the training programs available to help you implement them effectively.
Key Rules of Good Clinical Practices (Health Canada)
GCP Health Canada establish several key rules that researchers must follow. These include:
- Qualified Investigator (QI) Requirements – the QI must be qualified by education, training, and experience, and must supervise the conduct of the clinical trial
- Research Ethics Board (REB) Review – all clinical trials must be reviewed and approved by a REB before initiation
- Informed Consent – participants must provide informed consent before trial participation, with proper documentation
- Clinical Trial Application (CTA) – sponsors must submit a CTA to Health Canada for authorization
- Safety Reporting – adverse events, serious adverse events, and suspected unexpected serious adverse reactions must be reported within specified timelines
- Data Governance – data must be collected, recorded, and managed in accordance with ALCOA+ principles
- Record Keeping – essential documents and trial master files must be maintained
- Inspection Readiness – researchers must be prepared for Health Canada GCP inspections
How Researchers Can Ensure Compliance
Researchers can ensure compliance with Good Clinical Practices (Health Canada) by:
- Completing updated GCP training aligned with ICH E6(R3)
- Understanding Part C, Division 5 regulatory requirements
- Implementing quality management systems and risk-based monitoring
- Maintaining proper documentation and trial master files
- Preparing for Health Canada GCP inspections
Detailed Course Breakdown
Course 1: Good Clinical Practices (Health Canada)
This comprehensive training program provides clinical research professionals with the knowledge and practical skills required to conduct clinical trials in compliance with Health Canada Food and Drug Regulations (Part C, Division 5) and the ICH E6(R3) Good Clinical Practice (GCP) guideline.
Scope: The curriculum is aligned with Health Canada’s adoption of ICH E6(R3) effective April 1, 2026. It covers Health Canada regulatory requirements, sponsor and Qualified Investigator responsibilities, clinical trial application processes, informed consent, safety reporting, data governance, quality management, and inspection readiness.
Description of Modules: The curriculum covers:
- Health Canada regulatory requirements for clinical trials (Part C, Division 5)
- ICH E6(R3) Good Clinical Practice principles and Annex 1
- Sponsor, Qualified Investigator (QI), and Research Ethics Board (REB) responsibilities
- Clinical trial application (CTA) and amendment (CTA-A) processes
- Informed consent requirements and participant protection
- Safety reporting obligations (AEs, SAEs, SUSARs)
- Data governance and record keeping requirements
- Quality management and risk-based monitoring
- Investigational product management and GMP compliance
- Clinical trial inspections and enforcement
Target Audience:
- Sponsors (commercial and non-commercial/academic)
- Qualified Investigators (QIs) and Principal Investigators
- Sub-Investigators and clinical research staff
- Research Ethics Board (REB) members and administrators
- Clinical Research Coordinators and study site personnel
- Contract Research Organizations (CROs) and Service Providers
- Data managers and biostatisticians
- Clinical monitors and auditors
- Regulatory affairs professionals
- Quality assurance professionals
- Pharmacovigilance professionals
Pricing: Competitive pricing with group discounts available.
FAQ:
- What is a Qualified Investigator (QI) under Health Canada GCP? The QI is the legally defined role responsible for supervising the conduct of the clinical trial, qualified by education, training, and experience.
- What is the role of the Research Ethics Board (REB)? The REB provides ethical oversight and review of clinical trials, ensuring participant protection.
- What are the requirements for informed consent? Informed consent must be obtained from all participants before trial participation, with proper documentation.
- What is a Clinical Trial Application (CTA)? Sponsors must submit a CTA to Health Canada for authorization before initiating a clinical trial.
- What are the safety reporting timelines under Health Canada? Health Canada requires expedited reporting of serious adverse events and suspected unexpected serious adverse reactions within specified timelines.
Enroll Now: https://www.gxptrainings.com/courses/health-canada-good-clinical-practice-training/
Course 2: Good Clinical Practices (ICH E6(R3) Focused)
This comprehensive training program provides an in-depth exploration of the ICH E6(R3) Good Clinical Practice guideline.
Scope: The curriculum is structured to guide participants through the entire guideline, covering the 11 fundamental principles, the expanded roles and responsibilities of sponsors and investigators, rigorous data governance frameworks, and the critical requirements for essential records.
Description of Modules: The curriculum covers:
- ICH E6(R3) overview and its significance in global clinical research
- 11 Fundamental Principles of GCP and their application
- Sponsor responsibilities including oversight and quality management
- Investigator responsibilities including delegation and supervision
- Informed consent requirements and documentation
- Data governance and integrity frameworks
- Essential records and Trial Master File requirements
- Safety reporting and pharmacovigilance obligations
- Risk-based approaches to trial management
- Digital technologies and decentralized trial elements
Target Audience:
- Clinical Investigators and Sub-Investigators
- Sponsor Personnel (Medical, Regulatory, Clinical Operations)
- Clinical Research Associates (Monitors)
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Quality Assurance and Compliance Staff
- Clinical Trial Coordinators and Site Staff
- Pharmacovigilance and Safety Specialists
- Regulatory Affairs Professionals
- Clinical Research Organization (CRO) Personnel
Pricing: $149.00 with group discounts available.
FAQ:
- What are the 11 fundamental principles of GCP? They cover the ethical and scientific foundation of clinical trials, including participant safety, data integrity, and quality management.
- What is the role of the sponsor in GCP? Sponsors are responsible for initiating, managing, and financing clinical trials, and ensuring compliance with GCP requirements.
- What is the role of the investigator in GCP? Investigators are responsible for conducting the trial at the site, ensuring participant safety, and complying with the protocol and GCP requirements.
- What is the Trial Master File? It is a collection of essential documents that demonstrate compliance with GCP and regulatory requirements.
- What is the significance of Annex 1 in ICH E6(R3)? Annex 1 provides specific guidance on interventional clinical trials, building on the fundamental principles.
Enroll Now: https://www.gxptrainings.com/courses/ich-e6r3-good-clinical-practices-gcp/
Course 3: HIPAA Clinical Data Privacy, Security & Compliance Training
This training program provides organizations and individuals with a comprehensive understanding of the legal, regulatory, and operational requirements for protecting health information in clinical research and healthcare delivery settings.
Scope: The program covers the full spectrum of privacy, security, and compliance obligations under U.S. federal law and international good practice standards.
Description of Modules: The curriculum covers 10 comprehensive sections:
- HIPAA Overview and regulatory landscape
- HIPAA Privacy Rule requirements and PHI protections
- HIPAA Security Rule requirements and ePHI safeguards
- HIPAA Breach Notification Rule requirements
- GCP and clinical data integrity requirements
- Security controls for information systems and cloud environments
- Regulatory compliance frameworks including FDA, NIST, and ISO
- Incident management and breach response
- Risk assessment methodologies
- Roles and responsibilities of Sponsors, CROs, Investigators, and technology vendors
Target Audience:
- Covered Entities under HIPAA
- Business Associates and their subcontractors
- Clinical Research Professionals
- Security and Compliance Professionals
Pricing: $249.00 with group discounts available.
FAQ:
- Why is data privacy important in clinical research? It protects participant confidentiality and ensures compliance with regulatory requirements.
- What is Protected Health Information (PHI)? PHI is health information that identifies an individual or can be used to identify an individual.
- What is the difference between the HIPAA Privacy Rule and Security Rule? The Privacy Rule protects the privacy of PHI, while the Security Rule establishes standards for protecting ePHI.
- What is a breach under HIPAA? A breach is the unauthorized acquisition, access, use, or disclosure of PHI that compromises its security or privacy.
- How can researchers ensure HIPAA compliance? Compliance requires appropriate policies, training, technical safeguards, and oversight of business associates.
Enroll Now: https://www.gxptrainings.com/courses/hipaa-clinical-data-privacy-security-compliance-training/
Course 4: GCP Global Auditor Certification Program
This training program defines the complete knowledge and performance requirements for personnel involved in clinical research to become certified global auditors for Good Clinical Practice (GCP).
Scope: The program integrates GCP requirements from ICH E6(R3), Health Canada Part C, Division 5, and FDA regulations with auditing practices based on ISO 19011:2026.
Description of Modules: The curriculum covers:
- Regulatory Frameworks including ICH E6(R3), Health Canada Division 5, and FDA 21 CFR
- Auditing Practices based on ISO 19011:2026
- Remote auditing methods including virtual audits
- Second-party auditing including supplier qualification
Target Audience:
- Quality Assurance Personnel
- Clinical Research Associates (Monitors)
- Study Directors and Clinical Trial Managers
- Clinical Investigators and Site Staff
- Sponsor Personnel
- CRO Personnel
- IRB/IEC Members and Coordinators
Pricing: $499.00 with group discounts available.
FAQ:
- How does GCP auditing support research compliance? Auditing identifies and addresses non-conformities, ensuring that trials are conducted in accordance with GCP requirements.
- What are the key elements of a GCP audit? A GCP audit includes planning, preparation, execution, reporting, and follow-up of corrective actions.
- What is a non-conformity in GCP auditing? A non-conformity is a deviation from GCP requirements that can be classified as major, minor, or observation.
- What is the purpose of remote GCP auditing? Remote auditing enables efficient oversight of global trial sites, reducing travel costs and time.
- How are audit findings communicated? Audit findings are documented in an audit report and communicated to management for corrective action.
Enroll Now: https://www.gxptrainings.com/courses/gcp-global-auditor-certification-program/
Course 5: Certified Regulatory Affairs Professional (CRAP)
This comprehensive certification program provides regulatory professionals with end-to-end knowledge of the global pharmaceutical regulatory landscape.
Scope: The program covers the complete drug development lifecycle from discovery through post-approval lifecycle management.
Description of Modules: The curriculum covers:
- Global Regulatory Framework overview
- Investigational New Drug (IND) applications
- New Drug Applications (NDA) for innovative pharmaceuticals
- Abbreviated New Drug Applications (ANDA) for generics
- Biologics License Applications (BLA) for biological products
- Orphan Drug Designation for rare disease treatments
- Special Programs including Accelerated Approval and Breakthrough Therapy
- Post-approval lifecycle management
- Regulatory agency interactions and meeting management
- Global regulatory strategy development
Target Audience:
- Regulatory Affairs Professionals
- Pharmaceutical Development and Formulation Scientists
- Quality Assurance/Quality Control Professionals
- Clinical and Nonclinical Development Professionals
Pricing: $799.00 with group discounts available.
FAQ:
- How does regulatory affairs training support clinical research? It provides the knowledge needed to navigate complex regulatory requirements for clinical trials.
- What is the difference between an IND and an NDA? An IND authorizes clinical trials, while an NDA requests marketing approval.
- What is the eCTD format and why is it important? eCTD is the standard format for regulatory submissions.
- What is the purpose of an Orphan Drug Designation? It provides incentives for developing drugs for rare diseases.
- What is the role of ICH in global drug development? ICH harmonizes regulatory requirements across regions.
Enroll Now: https://www.gxptrainings.com/courses/certified-regulatory-affairs-professional/
Get Your Team Offer
For organizations looking to enroll multiple participants, we offer specialized team packages and volume discounts. Please reach out to our partnership team to discuss your specific needs and scores.
Contact Us: https://www.gxptrainings.com/contact-us/
Authors
